PDCD1 and cancer: Other immune subsets such as tumors-associated macrophages (TAMs), cancer-associated fibroblasts (CAFs) or regulatory T lymphocytes (Tregs) may be crucial in mediating immune tolerance and resistance (Figure 1) to PD-L1/PD-1 inhibition.